Literature DB >> 8031824

Cell-lytic and antibacterial peptides that act by perturbing the barrier function of membranes: facets of their conformational features, structure-function correlations and membrane-perturbing abilities.

G Saberwal1, R Nagaraj.   

Abstract

Almost all hemolytic and antimicrobial peptides form part of the defense mechanism of species widely distributed across the evolutionary scale. Although these peptides are of varying lengths and composition, they form amphiphilic structures in a hydrophobic environment. They also have the ability to form channels in natural and model membranes. Hemolytic peptides have proven to be very useful in studying the mechanism of hemolysis and the permeability properties of red blood cells. Preliminary investigations indicate that these peptides may also be useful in the investigation of complex cellular phenomena like exocytosis and neurotransmission. Although molecules like vancomycin, bacitracin and penicillins have been extensively used as antibiotics for therapeutic purposes, most species throughout the evolutionary scale use peptides as antimicrobial agents. These peptides exert their activity by altering the permeability properties of the bacterial plasma membrane and do not interfere with macro molecular synthesis like the other antibiotics that are presently used in therapies. Hence it is likely that resistance to peptide antibacterial agents may not develop easily. Since the problem of antibiotic resistance is presently a particularly severe one, peptide antibiotics may be the drugs of choice in the future.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8031824     DOI: 10.1016/0304-4157(94)90002-7

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  36 in total

1.  Characterization of the unique function of a reduced amide bond in a cytolytic peptide that acts on phospholipid membranes.

Authors:  J E Oh; K H Lee
Journal:  Biochem J       Date:  2000-12-15       Impact factor: 3.857

2.  Novel bifunctional inhibitor of xylanase and aspartic protease: implications for inhibition of fungal growth.

Authors:  C Dash; A Ahmad; D Nath; M Rao
Journal:  Antimicrob Agents Chemother       Date:  2001-07       Impact factor: 5.191

3.  Interaction of melittin with membrane cholesterol: a fluorescence approach.

Authors:  H Raghuraman; Amitabha Chattopadhyay
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

4.  Orientation and dynamics of melittin in membranes of varying composition utilizing NBD fluorescence.

Authors:  H Raghuraman; Amitabha Chattopadhyay
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

5.  Solid-state NMR analysis of the PGLa peptide orientation in DMPC bilayers: structural fidelity of 2H-labels versus high sensitivity of 19F-NMR.

Authors:  Erik Strandberg; Parvesh Wadhwani; Pierre Tremouilhac; Ulrich H N Dürr; Anne S Ulrich
Journal:  Biophys J       Date:  2005-12-09       Impact factor: 4.033

6.  Structure-function studies of Bubalus bubalis lingual antimicrobial peptide analogs.

Authors:  Dhruba Jyoti Kalita; Ashok Kumar; Satish Kumar
Journal:  Vet Res Commun       Date:  2008-07-24       Impact factor: 2.459

7.  Structure-activity relationships of αs-casein peptides with multifunctional biological activities.

Authors:  Srinivas Sistla
Journal:  Mol Cell Biochem       Date:  2013-08-21       Impact factor: 3.396

8.  In vitro microbicidal activities of cecropin peptides D2A21 and D4E1 and gel formulations containing 0.1 to 2% D2A21 against Chlamydia trachomatis.

Authors:  L M Ballweber; J E Jaynes; W E Stamm; M F Lampe
Journal:  Antimicrob Agents Chemother       Date:  2002-01       Impact factor: 5.191

9.  Comparison of the membrane association of two antimicrobial peptides, magainin 2 and indolicidin.

Authors:  H Zhao; J P Mattila; J M Holopainen; P K Kinnunen
Journal:  Biophys J       Date:  2001-11       Impact factor: 4.033

10.  Effect of micellar charge on the conformation and dynamics of melittin.

Authors:  H Raghuraman; Amitabha Chattopadhyay
Journal:  Eur Biophys J       Date:  2004-04-08       Impact factor: 1.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.